Case Study: Engineered Macrophage Immunotherapy: CARs & Beyond
Time: 1:30 pm
day: Conference Day Two
Details:
- Development of CAR-M immunotherapy
- First-in-human CAR-M phase I clinical data
- Next generation approaches
